NMIBC
Clinical trials for NMIBC explained in plain language.
Never miss a new study
Get alerted when new NMIBC trials appear
Sign up with your email to follow new studies for NMIBC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill aims to shrink bladder tumors before surgery
Disease control CompletedThis study tested if taking a targeted pill called pemigatinib for 4-6 weeks could shrink or eliminate recurrent, non-invasive bladder tumors before standard surgery. It involved 30 patients with a history of low- or intermediate-risk tumors that had come back. The main goal was …
Matched conditions: NMIBC
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New bladder cancer drug tested for safety in early trial
Disease control CompletedThis early-stage study tested the safety of a new drug called UGN-301 for people with recurring non-muscle invasive bladder cancer. The drug was delivered directly into the bladder, both by itself and combined with other treatments. The main goal was to find a safe dose and under…
Matched conditions: NMIBC
Phase: PHASE1 • Sponsor: UroGen Pharma Ltd. • Aim: Disease control
Last updated Mar 17, 2026 12:55 UTC